TRANSACT TECHNOLOGIES INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.66 USD | +1.67% |
|
+0.27% | -47.56% |
| Jun. 26 | TransAct Technologies Incorporated Announces First Epicentral Deployment in Asia | CI |
| Jun. 03 | TransAct Technologies Incorporated Announces Update to Strategic Business Review | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 81.95 | 63.4 | 107.2 | 62.64 | 69.51 | 35.98 | - |
| Enterprise Value (EV) 1 | 77.75 | 63.4 | 107.2 | 62.64 | 69.51 | 35.98 | 35.98 |
| P/E ratio | 157 x | -9.86 x | -24.2 x | -10.5 x | 14.9 x | -8.51 x | -22.9 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.79 x | 2.07 x | 2.72 x | 1.08 x | 0.96 x | 0.78 x | 0.64 x |
| EV / Revenue | 1.79 x | 2.07 x | 2.72 x | 1.08 x | 0.96 x | 0.78 x | 0.64 x |
| EV / EBITDA | 33.6 x | -10.7 x | -14.1 x | -12 x | 6.97 x | -11.5 x | 81.7 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | 3.25 x | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 7,470 | 8,929 | 9,835 | 9,912 | 9,958 | 9,995 | - |
| Reference price 2 | 10.97 | 7.100 | 10.90 | 6.320 | 6.980 | 3.660 | 3.660 |
| Announcement Date | 3/10/20 | 3/9/21 | 3/9/22 | 3/8/23 | 3/12/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 45.75 | 30.6 | 39.39 | 58.14 | 72.63 | 46.1 | 56.07 |
| EBITDA 1 | 2.441 | -5.899 | -7.63 | -5.206 | 9.968 | -3.122 | 0.4405 |
| EBIT 1 | 0.343 | -8.173 | -9.51 | -7.677 | 5.706 | -5.702 | -2.16 |
| Operating Margin | 0.75% | -26.71% | -24.15% | -13.2% | 7.86% | -12.37% | -3.85% |
| Earnings before Tax (EBT) 1 | 0.367 | -8.169 | -6.216 | -7.901 | 5.903 | -5.725 | -2.214 |
| Net income 1 | 0.516 | -5.63 | -4.145 | -5.936 | 4.748 | -4.314 | -1.64 |
| Net margin | 1.13% | -18.4% | -10.52% | -10.21% | 6.54% | -9.36% | -2.93% |
| EPS 2 | 0.0700 | -0.7200 | -0.4500 | -0.6000 | 0.4700 | -0.4300 | -0.1600 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 3/10/20 | 3/9/21 | 3/9/22 | 3/8/23 | 3/12/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 11.12 | 9.702 | 12.62 | 17.86 | 17.96 | 22.27 | 19.91 | 17.19 | 13.26 | 10.69 | 10.44 | 12.25 | 12.73 | 12.85 | 14.11 |
| EBITDA 1 | -2.109 | -4.687 | -2.536 | 1.165 | 1.28 | 4.464 | 3.175 | 1.742 | 0.587 | -0.701 | -1.451 | -0.6185 | -0.3825 | -0.356 | 0.1975 |
| EBIT 1 | -2.485 | -5.176 | -2.954 | 0.387 | 0.494 | 3.813 | 1.224 | 1.191 | -0.522 | -1.301 | -2.101 | -1.268 | -1.032 | -1.006 | -0.4525 |
| Operating Margin | -22.34% | -53.35% | -23.4% | 2.17% | 2.75% | 17.12% | 6.15% | 6.93% | -3.94% | -12.17% | -20.13% | -10.36% | -8.11% | -7.83% | -3.21% |
| Earnings before Tax (EBT) 1 | -1.124 | -5.275 | -3.246 | 0.466 | 0.582 | 3.768 | 1.156 | 1.075 | -0.096 | -1.313 | -2.114 | -1.282 | -1.046 | -1.02 | -0.466 |
| Net income 1 | -0.735 | -4.013 | -2.376 | 0.528 | 0.26 | 3.139 | 0.765 | 0.906 | -0.062 | -1.036 | -1.574 | -0.9545 | -0.7785 | -0.7595 | -0.3445 |
| Net margin | -6.61% | -41.36% | -18.82% | 2.96% | 1.45% | 14.1% | 3.84% | 5.27% | -0.47% | -9.69% | -15.09% | -7.79% | -6.12% | -5.91% | -2.44% |
| EPS 2 | -0.0700 | -0.4100 | -0.2400 | 0.0500 | 0.0300 | 0.3100 | 0.0800 | 0.0900 | -0.0100 | -0.1000 | -0.1600 | -0.0950 | -0.0750 | -0.0750 | -0.0350 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/9/22 | 5/10/22 | 8/17/22 | 11/10/22 | 3/8/23 | 5/9/23 | 8/9/23 | 11/9/23 | 3/12/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 4.2 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 1.93% | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | 3.380 | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 3/10/20 | 3/9/21 | 3/9/22 | 3/8/23 | 3/12/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.6
USD
Average target price
6.75
USD
Spread / Average Target
+87.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -47.56% | 35.98M | |
| +25.56% | 5.3B | |
| -5.14% | 3.78B | |
| -2.23% | 1.56B | |
| +35.51% | 1.52B | |
| -6.15% | 1.41B | |
| +32.05% | 1.26B | |
| +11.42% | 1.11B | |
| +117.67% | 843M | |
| -1.32% | 624M |
- Stock Market
- Equities
- TACT Stock
- Financials TransAct Technologies Incorporated
